BUDA JUICE INC (BUDA)
AMEXConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-10-15
$7.50-3.10%
Close 2026-10-16 · 1-day change
AMEXConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-10-15
Research Workspace
Put BUDA beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Staples is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisThis stock is highly volatile — it swings about 3% on a typical day and fell roughly 34% in its worst 12-month stretch.
View RiskBUDA’s steady recent performance supports a typical industry position, though its growth trajectory is unavailable. No earnings release is recorded, so recent revenue growth and the latest result cannot be verified. Retail expansion supports the positive outlook, but the desk lacks company earnings history. BUDA trades at 34× P/E versus a 16× peer median, near its 36× history. The price is roughly in line with the growth forecast. A 34% next-quarter miss probability and the peer valuation gap threaten the premium. Peer multiples imply a price about 101% below where it trades. Our read remains intact; this read is provisional.
Trailing returns as of 2026-10-16. BUDA is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 2 analysts currently covering BUDA (as of Oct 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare BUDA with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| BUDA Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 8 valuation methods, at three horizons. As of 2026-10-15. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Soft Drinks & Non-alcoholic Beverages — fair value, gap to price, and forward P/E.
Compare the value case
Put BUDA next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Analyst buy rating supports positive outlook on retail expansion.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-16. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Significant revenue growth supports positive valuation outlook.
